Alfredo Puing, MD
Assistant ProfessorDownloadHi-Res Photo
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAbout
Titles
Assistant Professor
Biography
Dr. Alfredo Puing is originally from Guayaquil, Ecuador. He earned his Doctor of Medicine (MD) degree from Universidad Central del Ecuador in Quito, Ecuador. He completed his Internal Medicine Residency at Saint Peter’s University Hospital in New Brunswick, New Jersey, and was the “Outstanding PGY-3” resident award recipient. Dr. Puing then pursued further specialization with fellowships in Infectious Diseases at the University of Texas Southwestern Medical Center in Dallas, Texas, and in Immunocompromised Host Infectious Diseases at Stanford University. Before joining Yale, Dr. Puing served for three years as an Assistant Clinical Professor in the Division of Infectious Diseases at City of Hope National Medical Center in Duarte, California. Dr. Puing has been actively involved in clinical research focusing on infectious diseases and immunocompromised patients.
Appointments
Infectious Diseases
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Stanford University (2020)
- Fellow
- University of Texas Southwestern Medical Center (2019)
- Resident
- Saint Peter’s University Hospital (2017)
- Intern
- Saint Peter’s University Hospital (2015)
- MD
- Universidad Central del Ecuador
Research
Research at a Glance
Publications Timeline
A big-picture view of Alfredo Puing's research output by year.
17Publications
21Citations
Publications
2024
Implementation and outcomes of beta-lactam allergy management protocol at a comprehensive cancer center.
So W, Khalak SI, Ho S, Ross JA, Dadwal SS, Puing AG, Nanayakkara DD, Kaur A, Taplitz RA, Dickter JK. Implementation and outcomes of beta-lactam allergy management protocol at a comprehensive cancer center. Infection 2024 PMID: 38907094, DOI: 10.1007/s15010-024-02274-1.Peer-Reviewed Original ResearchHIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.
Dickter JK, Aribi A, Cardoso AA, Gianella S, Gendzekhadze K, Li S, Feng Y, Chaillon A, Laird GM, Browning DL, Ross JA, Nanayakkara DD, Puing A, Stan R, Lai LL, Chang S, Kadambi TD, Thomas S, Al Malki MM, Nakamura R, Alvarnas J, Taplitz RA, Dadwal SS, Forman SJ, Zaia JA. HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2024, 390: 669-671. PMID: 38354149, DOI: 10.1056/NEJMc2312556.Peer-Reviewed Original Research
2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.
Chiuppesi F, Ortega-Francisco S, Gutierrez MA, Li J, Ly M, Faircloth K, Mack-Onyeike J, La Rosa C, Thomas S, Zhou Q, Drake J, Slape C, Fernando P, Rida W, Kaltcheva T, Grifoni A, Sette A, Patterson A, Dempsey S, Ball B, Ali H, Salhotra A, Stein A, Nathwani N, Rosenzweig M, Nikolaenko L, Al Malki MM, Dickter J, Nanayakkara DD, Puing A, Forman SJ, Taplitz RA, Zaia JA, Nakamura R, Wussow F, Diamond DJ, Dadwal SS. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy. Vaccines (Basel) 2023, 11 PMID: 37766168, DOI: 10.3390/vaccines11091492.Peer-Reviewed Original ResearchUse of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience.
Amanam I, Yao J, Puing A, Tsai NC, Samuels D, Ngo D, Ho S, Ali H, Aribi A, Arslan S, Artz A, Htut M, Koller P, Salhotra A, Sandhu K, Nikolaenko L, Pawlowska A, Shouse G, Stein A, Marcucci G, Forman S, Nakamura R, Dadwal S, Al Malki MM. Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer Med 2023, 12: 11248-11253. PMID: 37081733, DOI: 10.1002/cam4.5832.Peer-Reviewed Original ResearchTreatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience.
Tinajero J, Ngo D, Puing A, Koller P. Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience. Acta Haematol 2023, 146: 490-495. PMID: 38156364, DOI: 10.1159/000533346.Peer-Reviewed Original Research
2022
Oesophageal and pulmonary invasive aspergillosis in a patient with multiple myeloma.
Puing AG, Ross J, Parekh V, Nanayakkara DD. Oesophageal and pulmonary invasive aspergillosis in a patient with multiple myeloma. BMJ Case Rep 2022, 15 PMID: 35318199, DOI: 10.1136/bcr-2021-246403.Peer-Reviewed Case Reports and Technical NotesSuccessful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity.
Pourhassan H, La Rosa C, Chiuppesi F, Puing A, Aldoss I, Park Y, Zhou Q, Karpinski V, Faircloth K, Kaltcheva T, Johnson D, Francisco SO, Zaia JA, Nakamura R, Al Malki MM, Diamond DJ, Dadwal SS, Forman SJ. Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity. Blood Adv 2022, 6: 1645-1650. PMID: 35008104, DOI: 10.1182/bloodadvances.2021006282.Peer-Reviewed Case Reports and Technical NotesSafety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial
Chiuppesi F, Zaia J, Frankel P, Stan R, Drake J, Williams B, Acosta A, Francis K, Taplitz R, Dickter J, Dadwal S, Puing A, Nanayakkara D, Ash P, Cui Y, Contreras H, La Rosa C, Tiemann K, Park Y, Medina J, Iniguez A, Zhou Q, Karpinski V, Johnson D, Faircloth K, Kaltcheva T, Nguyen J, Kha M, Nguyen V, Francisco S, Grifoni A, Wong A, Sette A, Wussow F, Diamond D. Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial. The Lancet Microbe 2022, 3: e252-e264. PMID: 35287430, PMCID: PMC8906816, DOI: 10.1016/s2666-5247(22)00027-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPhase 1 trialVaccinia virus AnkaraPlacebo vaccineVirus AnkaraExact testDay 0SARS-CoV-2 antibodiesCOVID-19 vaccine candidatesHope Comprehensive Cancer CenterDose-expansion cohortsGrade 3 feverOpen-label cohortSevere adverse eventsAdditional secondary outcomesModified vaccinia virus AnkaraT cell responsesBody mass indexNegative pregnancy testComprehensive cancer centerSARS-CoV-2 spikeNucleocapsid-specific antibodiesFisher's exact testCOVID-19 vaccineSARS-CoV-2Plaque-forming unitsSevere Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.
Puing AG, Ho S, Frankel P, Tegtmeier B, Martin A, Ross J, Nanayakkara D, Dickter J, Seto T, Nakamura R, Taplitz R, Dadwal S. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience. J Infect Dis 2022, 225: 352-354. PMID: 34379763, DOI: 10.1093/infdis/jiab406.Commentaries, Editorials and Letters
2021
Impact of diabetes mellitus on clinical outcomes after heart transplantation.
Feng KY, Henricksen EJ, Wayda B, Moayedi Y, Lee R, Han J, Multani A, Yang W, Purewal S, Puing AG, Basina M, Teuteberg JJ, Khush KK. Impact of diabetes mellitus on clinical outcomes after heart transplantation. Clin Transplant 2021, 35: e14460. PMID: 34390599, DOI: 10.1111/ctr.14460.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity Infectious Diseases Society of America
Professional OrganizationsMemberDetails2017 - Presentactivity American Society of Transplantation
Professional OrganizationsMemberDetails2018 - Presentactivity American Society for Transplantation and Cellular Therapy
Professional OrganizationsMemberDetails2021 - Presentactivity City of Hope National Medical Center
CommitteesMemberDetailsPeer Review Committee2022 - 2023honor Trainee Travel Grant, IDWeek
National AwardIDSADetails10/02/2019United States
Clinical Care
Overview
Clinical Specialties
Infectious Diseases; Internal Medicine
Board Certifications
Infectious Disease
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2017
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.